Pre-purchase screening for Coxiella burnetii in small ruminants: farm acceptance and field evaluation identify the ex-vivo interferon-γ assay as a promising tool
Year: 2025
Type: article
Abstract: Introduction Q fever, caused by Coxiella burnetii , is a disease posing significant zoonotic risk and economic impact, particularly in small ruminants. Screening prior to flock introduction is essential for disease control and prevention, especially in breeding males, given their potential role in pathogen transmission. Methods This study combined a survey of small ruminant farmers with a field evaluation to explore the feasibility of pre-purchase screening and to compare the performance of four diagnostic tests: real-time qPCR, antibody ELISA, intradermal testing, and an ex-vivo interferon-gamma (IFN-γ) recall assay. Results The survey ( n = 114) revealed widespread gaps in health status awareness and a lack of pre-screening during animal lending or borrowing, with regional differences, although most farmers supported pre-purchase screening. The field evaluation across ten farms (five positive and five negative) showed that the IFN-γ recall assay provided diagnostic accuracy comparable to ELISA (DSe: 0.80 vs. 0.74; DSp: 0.94 vs. 0.96), with higher positivity rates among unvaccinated animals ( n = 122; 42.6% vs. 26.2%). The assay also proved feasible for field use, with a 24-hour antigen stimulation protocol performing equally good as the 48-hour version (AUC: 0.99 vs. 0.98). Real-time qPCR and intradermal testing showed the least utility under field conditions. Discussion Overall, the IFN-γ recall assay emerges as a promising diagnostic tool for detecting C. burnetii infection in small ruminants, particularly in settings where vaccination history is unknown or incomplete.
Source: Frontiers in Veterinary Science
Authors: Anneleen Matthijs, François Claine, Xavier Simons, Ana Soares, Damien Desqueper, Eva Van Mael, Marcella Mori
Institution: Sciensano (Belgium)
Language: English
Subfield: Parasitology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W4416975853
